Insulet Corp (NASDAQ:PODD)
| Market Cap | $9.24B-59.8% |
| Revenue (ttm) | $3.19B+26.5% |
| Net Income | $428.80M+74.2% |
| EPS | $6.14+78.0% |
| Shares Out | 69.37M |
| PE Ratio | 21.65 |
| Forward PE | 16.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,803,655 |
| Open | $135.34 |
| Previous Close | $137.23 |
| Day's Range | $132.34 - $140.40 |
| 52-Week Range | $126.40 - $342.13 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | $177.41(+33.22%) |
| Earnings Date | Feb 17, 2027 |
About PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
10 firms rating PODD in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 17, 2027Earnings report
$PODD stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of PODD by members of U.S. Congress
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 20, 2026 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 18, 2026 |
| Ro KhannaHouse / D | Purchase$1.00K – $15.00K | Sep 11, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Aug 18, 2026 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 17, 2019 |
| Gilbert CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 17, 2019 |
| Gilbert Ray CisnerosHouse / D | Sale$1.00K – $15.00K | Sep 16, 2019 |
| Josh GottheimerHouse / D | Sale$1.00K – $15.00K | Sep 13, 2019 |
Recently reported changes in PODD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PODD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PODD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PODD Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PODD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PODD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PODD
| VOOVanguard S&P 500 ETF | $275.93M |
| VTIVanguard Morningstar Total Stock Market ETF | $260.14M |
| VBVanguard Morningstar Small-Cap ETF | $232.71M |
| RSPInvesco S&P 500 Equal Weight ETF | $203.52M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $130.14M |
| IVViShares Core S&P 500 ETF | $128.17M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from PODD’s recent data — informational, not investment advice
What’s Behind the Score
News check: Multiple analyst downgrades (Baird to Neutral, Stifel cut after growth deceleration) outweigh valuation discussion pieces and board appointment news.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| PEPT | REX Peptide ETF | 7.90% |
| EDOC | Global X Telemedicine & Digital Health ETF | 4.64% |
| FDHT | FIDELITY DIGITAL HEALTH ETF | 4.57% |
| BTAL | AGF U.S. Market Neutral Anti-Beta Fund | 3.93% |
| TMED | T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF | 3.59% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 3.30% |
| HEAL | Global X HealthTech ETF | 2.96% |
| FORH | Formidable ETF | 2.11% |
| MDEV | First Trust Indxx Medical Devices ETF | 2.07% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.64% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.59% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 1.59% |
Weight is the stock’s share of each fund’s holdings.
